In conclusion, the main finding of this study was that MALAT1 acts as a tumour promoter at least in part by binding miR-217 and sequestering the molecule in the nucleus, thereby promoting oncogenic KRAS expression in PDAC. Here, KRAS is linked to neoplasm.